Switzerland
University Hospital Zurich - Department of Dermatology
cutaneous t cell lymphoma, maintenance treatment, resminostat, HDAC inhibitor
Metastatic melanomaRAF dimer inhibitorMAPK pathwaydual inhibitionNRAS mutation
Oncolytic virotherapy, non-specific cell infection, single-cell RNA sequencing, single cell immune repertoire profiling, T-VEC induced innate and adaptive immunity, primary cutaneous B-cell lymphoma
Meta-analysis, mucosal melanoma, Immune checkpoint inhibitor, survival benchmarks
clock-like signature, UV signature, COSMIC, mutation profiling, rapid progression